Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010

Anaerobe

Volumn 21, Issue , 2013, Pages 9-17

  Serafini, Fausta ^a   Strati, Francesco ^a   Ruas Madiedo, Patricia ^b   Turroni, Francesca ^a,c   Foroni, Elena ^a   Duranti, Sabrina ^a   Milano, Francesco ^a   Perotti, Alessio ^a   Viappiani, Alice ^a   Guglielmetti, Simone ^d   Buschini, Annamaria ^a   Margolles, Abelardo ^b   van Sinderen, Douwe ^c   Ventura, Marco ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Bifidobacteria; Intestinal adhesion; Pathogen inhibition; Probiotic

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; ERYTHROMYCIN; KANAMYCIN; PROBIOTIC AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT; BILE ACID; SODIUM CHLORIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CELL STRAIN CACO 2; CELL STRAIN HT29; CONTROLLED STUDY; CRONOBACTER SAKAZAKII; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ANTIBIOSIS; BIFIDOBACTERIUM; CACO 2 CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; FECES; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HT 29 CELL LINE; INFANT; INTESTINE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PH; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BIFIDUM; ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIAL ADHESION; BIFIDOBACTERIUM; BILE ACIDS AND SALTS; CACO-2 CELLS; CRONOBACTER SAKAZAKII; EPITHELIAL CELLS; ESCHERICHIA COLI; FECES; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HT29 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; INTESTINES; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; SODIUM CHLORIDE;

EID: 84877157158     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.03.003     Document Type: Article

References (56)

1. Marco M.L., Pavan S., Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 2006, 17:204-210.
2. Chenoll E., Casinos B., Bataller E., Astals P., Echevarria J., Iglesias J.R., et al. Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Appl Environ Microbiol 2011, 77:1335-1343.
3. Shirasawa Y., Shibahara-Sone H., Iino T., Ishikawa F. Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. JDairy Sci 2010, 93:4526-4534.
4. Khailova L., Mount Patrick S.K., Arganbright K.M., Halpern M.D., Kinouchi T., Dvorak B. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010, 299:G1118-G1127.
5. Philippe D., Heupel E., Blum-Sperisen S., Riedel C.U. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Int J Food Microbiol 2011, 149:45-49.
6. Fu Y.R., Yi Z.J., Pei J.L., Guan S. Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Microbiol Immunol 2010, 54:578-583.
7. Guglielmetti S., Mora D., Gschwender M., Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011, 33:1123-1132.
8. Malago J.J., Tooten P.C., Koninkx J.F. Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells. Benef Microbe 2010, 1:121-130.
9. Mouni F., Aissi E., Hernandez J., Gorocica P., Bouquelet S., Zenteno E., et al. Effect of Bifidobacterium bifidum DSM 20082 cytoplasmic fraction on human immune cells. Immunol Invest 2009, 38:104-115.
10. Tabbers M.M., de Milliano I., Roseboom M.G., Benninga M.A. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutr J 2011, 10:19.
11. Turroni F., Foroni E., Pizzetti P., Giubellini V., Ribbera A., Merusi P., et al. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ Microbiol 2009, 75:1534-1545.
12. Turroni F., Strati F., Foroni E., Serafini F., Duranti S., van Sinderen D., et al. Analysis of predicted carbohydrate transport systems encoded by Bifidobacterium bifidum PRL2010. Appl Environ Microbiol 2012.
13. Ventura M., O'Flaherty S., Claesson M.J., Turroni F., Klaenhammer T.R., van Sinderen D., et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol 2009, 7:61-71.
14. Turroni F., Bottacini F., Foroni E., Mulder I., Kim J.H., Zomer A., et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 2010, 107:19514-19519.
15. Schell M.A., Karmirantzou M., Snel B., Vilanova D., Berger B., Pessi G., et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A 2002, 99:14422-14427.
16. Lee J.H., Karamychev V.N., Kozyavkin S.A., Mills D., Pavlov A.R., Pavlova N.V., et al. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 2008, 9:247.
17. Sela D.A., Chapman J., Adeuya A., Kim J.H., Chen F., Whitehead T.R., et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A 2008, 105:18964-18969.
18. O'Connell Motherway M., Zomer A., Leahy S.C., Reunanen J., Bottacini F., Claesson M.J., et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A 2011, 108:11217-11222.
19. Pokusaeva K., Fitzgerald G.F., van Sinderen D. Carbohydrate metabolism in Bifidobacteria. Genes Nutr 2011, 6:285-306.
20. Turroni F., Foroni E., Montanini B., Viappiani A., Strati F., Duranti S., et al. Global genome transcription profiling of Bifidobacterium bifidum PRL2010 under invitro conditions and identification of reference genes for quantitative Real-Time PCR. Appl Environ Microbiol 2011.
21. Fanning S., Hall L.J., Cronin M., Zomer A., MacSharry J., Goulding D., et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 2012, 109:2108-2113.
22. Foroni E., Serafini F., Amidani D., Turroni F., He F., Bottacini F., et al. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microb Cell Fact 2011, 10(Suppl. 1):S16.
23. Simpson P.J., Fitzgerald G.F., Stanton C., Ross R.P. The evaluation of a mupirocin-based selective medium for the enumeration of bifidobacteria from probiotic animal feed. JMicrobiol Methods 2004, 57:9-16.
24. Ventura M., Elli M., Reniero R., Zink R. Molecular microbial analysis of Bifidobacterium isolates from different environments by the species-specific amplified ribosomal DNA restriction analysis (ARDRA). FEMS Microbiol Ecol 2001, 36:113-121.
25. Ryan S.M., Fitzgerald G.F., van Sinderen D. Screening for and identification of starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains. Appl Environ Microbiol 2006, 72:5289-5296.
26. Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J 2008, 732:1-15.
27. Rinkinen M., Westermarck E., Salminen S., Ouwehand A.C. Absence of host specificity for invitro adhesion of probiotic lactic acid bacteria to intestinal mucus. Vet Microbiol 2003, 97:55-61.
28. Collado M.C., Gueimonde M., Hernandez M., Sanz Y., Salminen S. Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. JFood Prot 2005, 68:2672-2678.
29. Ruas-Madiedo P., Gueimonde M., Fernandez-Garcia M., de los Reyes-Gavilan C.G., Margolles A. Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota. Appl Environ Microbiol 2008, 74:1936-1940.
30. Ruiz L., Gueimonde M., Coute Y., Salminen S., Sanchez J.C., de los Reyes-Gavilan C.G., et al. Evaluation of the ability of Bifidobacterium longum to metabolize human intestinal mucus. FEMS Microbiol Lett 2011, 314:125-130.
31. Moussavi M., Adams M.C. An invitro study on bacterial growth interactions and intestinal epithelial cell adhesion characteristics of probiotic combinations. Curr Microbiol 2010, 60:327-335.
32. Saxelin M., Lassig A., Karjalainen H., Tynkkynen S., Surakka A., Vapaatalo H., et al. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int J Food Microbiol 2010, 144:293-300.
33. Kiwaki M., Sato T. Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int J Food Microbiol 2009, 134:211-215.
34. Sonnenburg J.L., Angenent L.T., Gordon J.I. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?. Nat Immunol 2004, 5:569-573.
35. Ouwehand A.C., Tuomola E.M., Tolkko S., Salminen S. Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int J Food Microbiol 2001, 64:119-126.
36. Rautava S., Walker W.A. Commensal bacteria and epithelial cross talk in the developing intestine. Curr Gastroenterol Rep 2007, 9:385-392.
37. Guglielmetti S., Tamagnini I., Mora D., Minuzzo M., Scarafoni A., Arioli S., et al. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl Environ Microbiol 2008, 74:4695-4702.
38. Greene J.D., Klaenhammer T.R. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl Environ Microbiol 1994, 60:4487-4494.
39. Vizoso Pinto M.G., Schuster T., Briviba K., Watzl B., Holzapfel W.H., Franz C.M. Adhesive and chemokine stimulatory properties of potentially probiotic Lactobacillus strains. JFood Prot 2007, 70:125-134.
40. Hilgendorf C., Spahn-Langguth H., Regardh C.G., Lipka E., Amidon G.L., Langguth P. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. JPharm Sci 2000, 89:63-75.
41. López P.M.D., Gueimonde M., de los Reyes-Gavilán C.G., Margolles A., Suárez A., Ruas-Madiedo P. Exopolysaccharide-producing Bifidobacterium strains elicit different invitro responses upon interaction with human cells. Food Res Int 2012, 46:99-107.
42. Youakim A., Herscovics A. Cell surface glycopeptides from human intestinal epithelial cell lines derived from normal colon and colon adenocarcinomas. Cancer Res 1985, 45:5505-5511.
43. Farfan M.J., Cantero L., Vidal R., Botkin D.J., Torres A.G. Long polar fimbriae of enterohemorrhagic Escherichia coli O157:H7 bind to extracellular matrix proteins. Infect Immun 2011, 79:3744-3750.
44. Guglielmetti S., Tamagnini I., Minuzzo M., Arioli S., Parini C., Comelli E., et al. Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines. Curr Microbiol 2009, 59:167-172.
45. Freter M. Factors affecting the microecology of the gut 1992, Glasgow, UK.
46. Healy B., Cooney S., O'Brien S., Iversen C., Whyte P., Nally J., et al. Cronobacter (Enterobacter sakazakii): an opportunistic foodborne pathogen. Foodborne Pathog Dis 2010, 7:339-350.
47. Haraga A., Ohlson M.B., Miller S.I. Salmonellae interplay with host cells. Nat Rev Microbiol 2008, 6:53-66.
48. Thielman N.M., Guerrant R.L. Clinical practice. Acute infectious diarrhea. NEngl J Med 2004, 350:38-47.
49. Ina K., Kusugami K., Ohta M. Bacterial hemorrhagic enterocolitis. JGastroenterol 2003, 38:111-120.
50. Dhanani A.S., Bagchi T. Lactobacillus plantarum CS24.2 prevents E. coli adhesion to HT-29 cells and also down-regulates enteropathogen induced TNF-alpha and IL-8 expression. Microbiol Immunol 2013.
51. Lee Y.K., Puong K.Y., Ouwehand A.C., Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. JMed Microbiol 2003, 52:925-930.
52. Bujnakova D., Kmet V. Functional properties of Lactobacillus strains isolated from dairy products. Folia Microbiol (Praha) 2012.
53. Izquierdo E., Medina M., Ennahar S., Marchioni E., Sanz Y. Resistance to simulated gastrointestinal conditions and adhesion to mucus as probiotic criteria for Bifidobacterium longum strains. Curr Microbiol 2008, 56:613-618.
54. Bibiloni R., Fernando P., De Antoni G.L. Will a high adhering capacity in a probiotic strain guarantee exclusion of pathogens from intestinal epithelia. Anaerobe 1999, 5:519-524.
55. Meile L., Ludwig W., Rueger U., Gut C., Kaufmann P., Dasen G., et al. Bifidobacterium lactis sp. nov, a moderately oxygen tolerant species isolated from fermented milk. Syst Appl Microbiol 1997, 20:57-64.
56. Turroni F., Foroni E., Serafini F., Viappiani A., Montanini B., Bottacini F., et al. Ability of Bifidobacterium breve to grow on different types of milk: exploring the metabolism of milk through genome analysis. Appl Environ Microbiol 2011, 77:7408-7417.